+966 11 277 7729

Blogadmin2024-11-26T02:17:26+03:00

Understanding RMP & RMMs in SFDA PV Regulation

By Yara Aljadeed|2024-11-23T00:49:21+03:0009/06/2024|

Scientific Office Requirements by SFDA

By Regulatory Editor|2024-11-01T04:35:35+03:0001/03/2024|

Reporting Medical Device Incidents & Adverse Events to SFDA

By Heba Rasheed|2024-11-01T04:16:55+03:0023/02/2024|

Breakthrough Medicines Designation in SFDA

By Madiha Baaj|2024-11-01T04:11:32+03:0012/02/2024|

How to implement PMCF in Saudi Arabia

By Heba Rasheed|2024-11-01T03:57:38+03:0009/02/2024|

Understanding Orphan Drug Designation (ODD) in SFDA

By Madiha Baaj|2024-11-01T03:48:06+03:0009/02/2024|

Drug Information and Stock Reporting to SFDA (SDI)

By Rawd Alsubaie|2024-11-01T02:14:45+03:0010/01/2024|

Saudi PV Sub System (PSSF)

By Regulatory Editor|2024-10-30T21:10:32+03:0010/12/2023|

Product Recall in Saudi Arabia

By Nouf Almadallah|2024-10-30T21:00:15+03:0029/09/2023|

SDEA Agreement Requirements by SFDA

By Nouf Almadallah|2024-10-30T20:53:31+03:0002/09/2023|

12 Next

Request a Service

Our team is ready to answer your questions. Send your inquiries, request a proposal, or schedule an exploratory meeting.